Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Regeneron Pharmaceuticals, Inc. | StockGist | StockGist

Companies
REGN
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings REGNSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Regeneron Pharmaceuticals, Inc.

Filed Mar 27, 2026

Accepted Mar 27, 2026, 11:37 AM ET

CIK 0000872589

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

REGENERON PHARMACEUTICALS, INC.

Person Type

IA

Recent Filings

Regeneron Pharmaceuticals, Inc.1 months ago

Regeneron Pharmaceuticals, Inc.1 months ago

Regeneron Pharmaceuticals, Inc.2 months ago

Regeneron Pharmaceuticals, Inc.2 months ago

Regeneron Pharmaceuticals, Inc.4 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice